Tuula Pirttilä

Tuula Pirttilä publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Tuula Pirttilä sits on this spectrum.

Tuula Pirttilä D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Tuula Pirttilä sits on this spectrum.

Best Publications

• CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

  Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

  1417
  Citations

• Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

  Tero Tapiola;Irina Alafuzoff;Sanna-Kaisa Herukka;Laura Parkkinen

  1030
  Citations

• Plasma and cerebrospinal fluid Levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease

  Pankaj D. Mehta;Tuula Pirttilä;Sangita P. Mehta;Eugene A. Sersen

  865
  Citations

• Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

  Pieter Jelle Visser;Pieter Jelle Visser;Frans Verhey;Dirk L Knol;Philip Scheltens

  814
  Citations

• CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

  Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski

  737
  Citations

• Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

  Laura Parkkinen;Tuula Pirttilä;Irina Alafuzoff

  412
  Citations

• Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

  Katharina Buerger;Raymond Zinkowski;Stefan J. Teipel;Tero Tapiola

  360
  Citations

• Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

  P.D Mehta;T Pirttila;B.A Patrick;M Barshatzky

  332
  Citations

• Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

  Laura Parkkinen;Tarja Kauppinen;Tuula Pirttilä;Jaana M. Autere

  318
  Citations

• Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.

  Kristiina Karttunen;Pertti Karppi;Asta Hiltunen;Matti Vanhanen

  297
  Citations

• Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

  Ville Leinonen;Irina Alafuzoff;Sargo Aalto;Timo Suotunen

  295
  Citations

• CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.

  Sanna-Kaisa Herukka;Merja Hallikainen;Hilkka Soininen;Tuula Pirttilä

  285
  Citations

• Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

  Elina M Sutinen;Tuula Pirttilä;George Anderson;Antero Salminen

  259
  Citations

• Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients

  Johanna Ojala;Irina Alafuzoff;Sanna-Kaisa Herukka;Thomas van Groen;Thomas van Groen

  255
  Citations

• Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers.

  Khalid Iqbal;Michael Flory;Sabiha Khatoon;Hilkka Soininen

  221
  Citations

• A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.

  N. A. Verwey;W M van der Flier;K Blennow;C Clark

  206
  Citations

• Association Between Blood Pressure and Survival over 9 Years in a General Population Aged 85 and Older

  Sari Rastas;Tuula Pirttilä;Petteri Viramo;Auli Verkkoniemi

  201
  Citations

• Proteomic analysis of protein oxidation in Alzheimer's disease brain.

  Minna A. Korolainen;Gundars Goldsteins;Irina Alafuzoff;Jari Koistinaho

  190
  Citations

• Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

  Ville Leinonen;Anne M. Koivisto;Anne M. Koivisto;Sakari Savolainen;Jaana Rummukainen

  190
  Citations

• Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

  Terho Lehtimäki;Tuula Pirttilä;Pankaj D. Mehta;Henryk M. Wisniewski

  178
  Citations

• Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease

  Tero Tapiola;Tuula Pirttilä;Mia Mikkonen;Pankaj D. Mehta

  176
  Citations